{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Tian J"],"funding":["Science and Technology Department of Henan Province","Zhengzhou University"],"pagination":["790832"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8906509"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["12"],"pubmed_abstract":["Medication safety and efficacy-related pharmacogenomic research play a critical role in precision medicine. This study comprehensively analyzed the pharmacogenomic profiles of the central Han Chinese population in the context of medication safety and efficacy and compared them with other global populations. The ultimate goal is to improve medical treatment guidelines. We performed whole-genome sequencing in 487 Han Chinese individuals and investigated the allele frequencies of pharmacogenetic variants in 1,731 drug response-related genes. We identified 2,139 (81.18%) previously reported variants in our population with annotations in the PharmGKB database. The allele frequencies of these 2,139 clinical-related variants were similar to those in other East Asian populations but different from"],"journal":["Frontiers in pharmacology"],"pubmed_title":["Genetic Epidemiology of Medication Safety and Efficacy Related Variants in the Central Han Chinese Population With Whole Genome Sequencing."],"pmcid":["PMC8906509"],"funding_grant_id":["SBGJ2018041 192102310216","20XTZX05014"],"pubmed_authors":["Tian J","Yang Z","Li S","Guo J","Zhang J","Yang B","Shi J","Hou X","Xu H","Feng S","Ren S","Xue X"],"additional_accession":[]},"is_claimable":false,"name":"Genetic Epidemiology of Medication Safety and Efficacy Related Variants in the Central Han Chinese Population With Whole Genome Sequencing.","description":"Medication safety and efficacy-related pharmacogenomic research play a critical role in precision medicine. This study comprehensively analyzed the pharmacogenomic profiles of the central Han Chinese population in the context of medication safety and efficacy and compared them with other global populations. The ultimate goal is to improve medical treatment guidelines. We performed whole-genome sequencing in 487 Han Chinese individuals and investigated the allele frequencies of pharmacogenetic variants in 1,731 drug response-related genes. We identified 2,139 (81.18%) previously reported variants in our population with annotations in the PharmGKB database. The allele frequencies of these 2,139 clinical-related variants were similar to those in other East Asian populations but different from","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021","modification":"2026-05-30T15:14:47.673Z","creation":"2025-04-19T22:37:41.993Z"},"accession":"S-EPMC8906509","cross_references":{"pubmed":["35280256"],"doi":["10.3389/fphar.2021.790832"]}}